Dr. Savaş Tuna

Dr. Savaş Tuna is a highly experienced medical oncologist with over 30 years of practice in the treatment of various cancers. After completing his medical education at Istanbul University, School of Medicine, he pursued his specialization in internal medicine and then in medical oncology at the Istanbul University Oncology Institute.

Throughout his distinguished career, Dr. Tuna has specialized in the use of chemotherapy, targeted drugs, and immunotherapy for cancer treatment, working with a wide range of cancers including breast cancer, lung cancer, and gastrointestinal cancers. He is also highly skilled in cancer vaccines and complementary therapies, ensuring holistic care for his patients.

Dr. Tuna has worked with several prominent hospitals in Turkey, including Etimesgut Air Hospital, Eitimim and Research Hospital, Ankara Atatürk Training and Research Hospital, and Medical Park Bahçelievler. His multidisciplinary approach to cancer treatment and his commitment to providing high-quality care has earned him recognition in the medical community.

Dr. Tuna has been actively involved in cancer research, particularly in the areas of chemotherapy, targeted drug therapies, and immunotherapy. His research has contributed to better understanding the molecular basis of cancer and the development of more effective treatment options.

He has published research papers in leading oncology journals, and his findings have been presented at international conferences. Dr. Tuna's research is focused on improving the survival rates of cancer patients through innovative therapies and enhancing the effectiveness of existing treatments.

• Excellence in Medical Oncology – Turkish Medical Oncology Association (TTOD) (2015)

• Outstanding Contribution to Cancer Research – Awarded by the Turkish Internal Medicine Specialist Association (TİHOD) (2017)

• Top Oncologist of the Year – Recognized by the Turkish Oncology Society (2019)

• Best Palliative Care Specialist – Awarded by the Turkish Association of Cancer Care (2020)

Dr. Tuna has authored numerous research papers in medical oncology, particularly in the areas of immunotherapy and targeted therapy for cancer. One of his key publications, "Advancements in Targeted Cancer Therapy: Overcoming Resistance and Improving Outcomes," was published in The Journal of Clinical Oncology (2018). This paper discussed the latest advances in targeted therapies, particularly in overcoming resistance in metastatic cancers.

Additionally, Dr. Tuna has contributed to the development of palliative care strategies for cancer patients, with his work published in Cancer Research and The Lancet Oncology. His research continues to shape oncology practices, particularly in improving patient quality of life and survival rates.